NOTCH3 and breast cancer: Dysregulated NOTCH3 expression has often been linked to a more aggressive disease (23), and in triple-negative breast cancer reported as an oncogene (24, 25), while in luminal breast cancer, NOTCH3 upregulation has been associated with increased relapse-free survival (26, 27).